BioregulatorResearch
Bonomarlot
Also known as: A-20 · Bone Marrow Cytomax
A Cytomax bioregulator from bone marrow for treating anemia, post-chemotherapy recovery, and hematopoietic stem cell restoration.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~30 minutes
Typical Dose
Per bioregulator protocol
Administration
Oral capsule
Mechanism of Action
Bone marrow-derived peptide complex that stimulates hematopoietic stem cell proliferation and blood cell production.
Key Research Areas
bioregulatorbone marrowanemiahematopoietic
Frequently Asked Questions
What is Bonomarlot?▾
A Cytomax bioregulator from bone marrow for treating anemia, post-chemotherapy recovery, and hematopoietic stem cell restoration.
How does Bonomarlot work?▾
Bone marrow-derived peptide complex that stimulates hematopoietic stem cell proliferation and blood cell production.
What is the recommended dosage for Bonomarlot?▾
The typical research dosage is Per bioregulator protocol, administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Bonomarlot?▾
The half-life of Bonomarlot is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Bonomarlot FDA approved?▾
Bonomarlot is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Bonomarlot is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.